• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性异常纤溶酶原,法兰克福I型,复发性静脉血栓形成的一个原因。

Congenital abnormal plasminogen, Frankfurt I, a cause for recurrent venous thrombosis.

作者信息

Scharrer I, Hach-Wunderle V, Wohl R C, Sinio L, Boreisha I, Robbins K C

机构信息

Dept. of Internal Medicine, University Hospital, Frankfurt/Main, FRG.

出版信息

Haemostasis. 1988;18 Suppl 1:77-86. doi: 10.1159/000215841.

DOI:10.1159/000215841
PMID:2965086
Abstract

A new abnormal plasminogen, Frankfurt I, has been identified in the plasma of a 42 year-old male patients who had recurring thromboses, thrombophlebitis and pulmonary embolism since his age of 29. Reduced functional and also slightly reduced antigen plasminogen concentrations were found in both the proposituts and his mother. Plasmin generation rates carried out by Streptokinase and Urokinase were also abnormal. The plasmin generated was very unstable in the absence of stabilizing ligands and/or substrates. Crossed immunoelectrophoresis of the purified Frankfurt I revealed a peak with normal size and shape, but displaced with respect to normal Glu-plasminogen toward the anode. Isoelectric focusing followed by zymography on an agarose-fibrin plate proved this observation but did not indicate a separation of the normal from the abnormal plasminogen molecular species, also, fewer bands were found in the abnormal plasminogen isozyme pattern. Kinetic studies of Frankfurt I Glu-plasminogen and plasmin showed that most of the functional abnormality is related to absence of active sites in half of the molecules.

摘要

在一名42岁男性患者的血浆中发现了一种新的异常纤溶酶原,即法兰克福I型。该患者自29岁起就反复出现血栓形成、血栓性静脉炎和肺栓塞。在患者及其母亲体内均发现功能性纤溶酶原浓度降低,抗原纤溶酶原浓度也略有降低。由链激酶和尿激酶进行的纤溶酶生成率也异常。在没有稳定配体和/或底物的情况下,生成的纤溶酶非常不稳定。对纯化的法兰克福I型进行交叉免疫电泳显示,有一个峰,其大小和形状正常,但相对于正常的谷氨酸纤溶酶原向阳极偏移。在琼脂糖-纤维蛋白平板上进行等电聚焦后再进行酶谱分析证实了这一观察结果,但未显示正常和异常纤溶酶原分子种类的分离,而且在异常纤溶酶原同工酶图谱中发现的条带较少。对法兰克福I型谷氨酸纤溶酶原和纤溶酶的动力学研究表明,大多数功能异常与一半分子中活性位点的缺失有关。

相似文献

1
Congenital abnormal plasminogen, Frankfurt I, a cause for recurrent venous thrombosis.先天性异常纤溶酶原,法兰克福I型,复发性静脉血栓形成的一个原因。
Haemostasis. 1988;18 Suppl 1:77-86. doi: 10.1159/000215841.
2
Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis.先天性异常纤溶酶原法兰克福I型的研究及其与血栓形成的关系。
Thromb Haemost. 1986 Jun 30;55(3):396-401.
3
Abnormal plasminogen Maywood I.异常纤溶酶原 梅伍德I型
Thromb Haemost. 1991 Nov 1;66(5):575-80.
4
Congenital deficiency of plasminogen and its relationship to venous thrombosis.纤溶酶原先天性缺乏及其与静脉血栓形成的关系。
Thromb Haemost. 1988 Apr 8;59(2):277-80.
5
Plasminogen San Antonio: an abnormal plasminogen with a more cathodic migration, decreased activation and associated thrombosis.纤溶酶原圣安东尼奥型:一种具有更向阴极迁移、活化降低并伴有血栓形成的异常纤溶酶原。
Thromb Haemost. 1988 Feb 25;59(1):49-53.
6
Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis.异常纤溶酶原。在一名复发性血栓形成患者中发现的一种遗传性分子异常。
J Clin Invest. 1978 May;61(5):1186-95. doi: 10.1172/JCI109034.
7
alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
J Clin Invest. 1987 Nov;80(5):1391-400. doi: 10.1172/JCI113217.
8
Classification of abnormal plasminogens: dysplasminogenemias.异常纤溶酶原的分类:异常纤溶酶原血症。
Semin Thromb Hemost. 1990 Jul;16(3):217-20. doi: 10.1055/s-2007-1002672.
9
The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.纤维蛋白原比塞特尔II(γ亚基天冬酰胺308突变为赖氨酸)的突变不影响组织型纤溶酶原激活物(t-PA)和纤溶酶原与纤维蛋白的结合。
Blood Coagul Fibrinolysis. 1993 Oct;4(5):679-87.
10
Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.肌动蛋白可通过组织型和尿激酶型纤溶酶原激活剂刺激纤溶酶的生成。
Arch Biochem Biophys. 1993 Nov 15;307(1):138-45. doi: 10.1006/abbi.1993.1572.